Gliogene, a study that aims to identify hereditary links of glioma, a rare and deadly form of brain cancer, has begun recruiting families affected by the disease in order to identify genes that contribute to its onset and inform susceptibility.
In a new study, ethics scholar Dr. Stephanie Morain explores a trend of oncology trial recruitment via mobile apps, and what these app companies and consumers need to consider in terms of privacy and data protection
Analyzing both the entire set of genes and all the proteins produced by colon cancer tissues from patient samples has revealed a more comprehensive view of the tumor that points at novel cancer biological mechanisms and possible new therapeutic strategies.
A multidisciplinary, international team of scientists has been awarded Cancer Research UK’s Grand Challenge, an ambitious series of £20 million global grants tackling some of the toughest questions in cancer research.
A team of scientists found that the Transforming Growth Factor beta (TGF-beta) signaling pathway in uterine cells protects against uterine cancer by suppressing the overgrowth and transformation into cancer cells of the endometrium.
A team led by researchers at Baylor College of Medicine and the University of Texas at Austin has applied an unconventional approach that used bacteria to discover human proteins that can lead to DNA damage and promote cancer.
A study reveals that when Dna2 is absent, small DNA fragments jump from all over the genome into chromosome breaks. This novel mechanism may explain similar events commonly seen in cancer or during antibody diversification.
A team of researchers shows Food and Drug Administration (FDA)-approved compounds can stop cancer growth and can potentially lead to the discovery of drugs in a way that is quicker and less expensive than traditional drug development strategies.
Dr. Tao Wu recently joined the Department of Molecular and Human Genetics at Baylor College of Medicine as an assistant professor through a $2 million recruitment grant from the Cancer Prevention and Research Institute of Texas (CPRIT).
In a recent study, researchers combined clinical and laboratory studies to show the PPM1D gene can confer blood cells exposed to the chemotherapy agent cisplatin a survival advantage that might favor the development of leukemia years later.